NCT04642911View on ClinicalTrials.gov

Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy

Active, not recruitingOBSERVATIONAL
Enrollment

91

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

October 10, 2030

Conditions
Diabete Type 2Mesenchymal Stem Cell
Interventions
OTHER

Long term follow up

Undergo long term follow up, including copy number measurement safety evaluations diseases specific product (Mesenchymal Stem Cell) in a Ukraine Association of Biobank bio-sponsored clinical trial who agree to participate in this study

Trial Locations (1)

Unknown

Institute of Bio-Stem Cell Rehabilitation, Kharkiv

All Listed Sponsors
lead

Ukraine Association of Biobank

OTHER